Key result
Dexmedetomidine use during electrophysiologic procedures may contribute to profound cardiogenic shock, particularly in patients dependent on high sympathetic tone or with preexisting hypovolemia.
Answers are grounded in this paper and cite their sources.
Dexmedetomidine should be avoided as an anesthetic agent in patients dependent on high sympathetic tone or undergoing procedures where complications may require high sympathetic tone, due to the risk of profound cardiogenic shock.
In Response: The key finding in this case was the development of profound cardiogenic shock after restoration of the patient's vital signs following pericardiocenthesis for cardiac tamponade.1 The patient was continuously monitored with cardiac ultrasound and fluoroscopy before and at the onset of tamponade, as per our protocol during atrial fibrillation ablation, as well as throughout resuscitation. The period of tamponade was brief and pericardiocenthesis was performed within minutes of the development of tamponade. Indeed, after pericardiocenthesis the patient was observed to have a normally contracting left ventricle. This was followed by a sudden deterioration in his cardiac status. Dr. Hutchens believes that polycythemia vera and left ventricular hypertrophy reduced the patient's coronary perfusion.2 Unfortunately, this scenario is untenable because the patient had a normal hematocrit and only very mild hypertrophy. There is no likelihood that this would create the profound shock observed in this patient. The fact that the autopsy later revealed diffuse myocardial necrosis is also not surprising because the patient's subsequent shock was prolonged and profound and created multi-organ hypoperfusion. It more likely resulted from the prolonged arrest rather than from the initial phase. Drs. Fischer and Silverstein believed the patient likely ruptured a plaque leading to coronary thrombosis, facilitated by some combination of polycythemia, hypotension, hypertension, and protamine administration.3 At the time of profound cardiogenic shock, there was no evidence of coronary ischemia, so this scenario is dismissed; the ST elevation suggesting coronary ischemia was observed later in the arrest. As mentioned previously, the patient's hematocrit was normal and no hypertension was observed during the arrest. Importantly, the autopsy also found no evidence to support the scenario. Cardiac tamponade was diagnosed immediately, as described above, so there was no delay in diagnosis, although Drs. Fischer and Silverstein believed the diagnosis can be challenging. Finally, they question the absence of right ventricular dysfunction in the presence of severe left ventricular dysfunction. As cardiologists, we commonly see severe left ventricular dysfunction and preserved right ventricle function, simply because the right ventricle functions as a passive pump and does not face the same afterload demands that the left ventricle does. We concur entirely with the editorial by Drs. Talke and Maze implicating the profound and potent sympatholytic effects of dexmetomidine.4 Moreover, this was the second case in our institution during which dexmetomidine appeared to contribute to cardiogenic shock. The first case was more clear-cut and has been previously published and undoubtedly sensitized us to concerns with this second case.5 Briefly, the previous patient was simply in the laboratory being prepped before an electrophysiologic procedure had even begun when sedation was initiated, and moments later went into cardiogenic shock, with autopsy revealing no plausible explanation. This patient's echocardiogram also revealed virtual left ventricular standstill. Both patients in whom we implicate dexmetomidine had completely normal left ventricular function prior to the procedure. We do agree with the concern raised by Stamenkovic et al.6 that preexisting hypovolemia, similar to a reduced preload of tamponade, can critically aggravate the side effects of dexmedetomidine. Thus, we believe the take home message is important: for patients dependent on high sympathetic tone, or who undergo procedures that may require high sympathetic tone should complications develop, dexmetomidine should be avoided as an anesthetic agent. We further want to emphasize the importance of publishing postmarketing case reports to identify rare but serious adverse effects or idiosyncratic reactions of approved medications to alert physicians to use caution and uncover similar otherwise unrecognized events. Tina C. Sichrovsky, MD Suneet Mittal, MD Jonathan S. Steinberg, MD St. Luke's-Roosevelt Hospital Center/Columbia University New York, New York [email protected]
No takes yet. Share an insight, caveat, or question.
Sichrovsky et al. (2008) conducted a letter in Cardiogenic shock (n=2). Dexmedetomidine was evaluated on Cardiogenic shock. Dexmedetomidine use during electrophysiologic procedures may contribute to profound cardiogenic shock, particularly in patients dependent on high sympathetic tone or with preexisting hypovolemia.
Synapse has enriched 10 related papers. Consider them for comparative context: